Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 16 AL 30

PUBMED

Cerebrospinal fluid neurogranin and TREM2 in Huntington's disease.

Byrne LM, Rodrigues FB, Johnson EB, De Vita E, Blennow K, Scahill R, Zetterberg H, Heslegrave A, Wild EJ.

Sci Rep. 2018 Mar 9;8(1):4260. doi: 10.1038/s41598-018-21788-x.

0

0

0

PUBMED

TSPO-PET Imaging Using [18F]PBR06 is a Potential Translatable Biomarker for Treatment Response in Huntington's Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31.

Simmons DA, James ML, Belichenko NP, Semaan S, Condon C, Kuan J, Shuhendler AJ, Miao Z, Chin FT, Longo FM.

Hum Mol Genet. 2018 May 30. doi: 10.1093/hmg/ddy202. [Epub ahead of print]

0

0

0

PUBMED

Huntington's Disease and Employment: The Relative Contributions of Cognitive and Motor Decline to the Decision to Leave Work.

Watkins K, Purks J, Kumar A, Sokas RK, Heller H, Anderson KE.

J Huntingtons Dis. 2018 Sep 4. doi: 10.3233/JHD-180296. [Epub ahead of print]

0

0

0

PUBMED

Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington's Disease.

Virlogeux A, Moutaux E, Christaller W, Genoux A, Bruyère J, Fino E, Charlot B, Cazorla M, Saudou F.

Cell Rep. 2018 Jan 2;22(1):110-122. doi: 10.1016/j.celrep.2017.12.013.

0

0

0

PUBMED

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Harding RJ, Tong YF.

Acta Pharmacol Sin. 2018 May;39(5):754-769. doi: 10.1038/aps.2018.11. Epub 2018 Apr 5. Review.

0

0

0

PUBMED

A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci.

Baine FK, Peerbhai N, Krause A.

J Neurol Sci. 2018 Jul 15;390:200-204. doi: 10.1016/j.jns.2018.04.031. Epub 2018 Apr 21.

0

0

0

PUBMED

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, Arning L, Ellrichmann G.

Exp Neurol. 2018 Jan 6;302:112-128. doi: 10.1016/j.expneurol.2018.01.001. [Epub ahead of print]

0

0

0

PUBMED

Epileptic chorea: Another window into neural networks?

Gameleira FT, Alúcio KT, de Paiva MLMN, de Lima Carlos KC, de Lima KM, Gameleira MH, Kauffman MA, Espay AJ.

J Neurol Sci. 2018 Nov 15;394:138-140. doi: 10.1016/j.jns.2018.09.009. Epub 2018 Sep 11. No abstract available.

0

0

0

PUBMED

Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism.

Skotte NH, Andersen JV, Santos A, Aldana BI, Willert CW, Nørremølle A, Waagepetersen HS, Nielsen ML.

Cell Rep. 2018 May 15;23(7):2211-2224. doi: 10.1016/j.celrep.2018.04.052.

0

0

0

PUBMED

Perspectives on Genetic Testing and Return of Results from the First Cohort of Presymptomatically Tested Individuals At Risk of Huntington Disease.

Stuttgen KM, Bollinger JM, Dvoskin RL, McCague A, Shpritz B, Brandt J, Mathews DJH.

J Genet Couns. 2018 Jul 2. doi: 10.1007/s10897-018-0274-0. [Epub ahead of print]

0

0

0

PUBMED

EEG may serve as a biomarker in Huntington's disease using machine learning automatic classification.

Odish OFF, Johnsen K, van Someren P, Roos RAC, van Dijk JG.

Sci Rep. 2018 Oct 31;8(1):16090. doi: 10.1038/s41598-018-34269-y.

0

0

0

PUBMED

Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model.

Dargaei Z, Bang JY, Mahadevan V, Khademullah CS, Bedard S, Parfitt GM, Kim JC, Woodin MA.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1618-E1626. doi: 10.1073/pnas.1716871115. Epub 2018 Jan 30.

0

0

0

PUBMED

Chorea-acanthocytosis: Homozygous 1-kb deletion in VPS13A detected by whole-genome sequencing.

Walker S, Dad R, Thiruvahindrapuram B, Ullah MI, Ahmad A, Hassan MJ, Scherer SW, Minassian BA.

Neurol Genet. 2018 May 18;4(3):e242. doi: 10.1212/NXG.0000000000000242. eCollection 2018 Jun.

0

0

0

PUBMED

Effects of multidisciplinary therapy on physical function in Huntington's disease.

Cruickshank TM, Reyes AP, Penailillo LE, Pulverenti T, Bartlett DM, Zaenker P, Blazevich AJ, Newton RU, Thompson JA, Lo J, Ziman MR.

Acta Neurol Scand. 2018 Jul 30. doi: 10.1111/ane.13002. [Epub ahead of print]

0

0

0

PUBMED

Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility study.

Yhnell E, Furby H, Breen RS, Brookes-Howell LC, Drew CJG, Playle R, Watson G, Metzler-Baddeley C, Rosser AE, Busse ME.

Pilot Feasibility Stud. 2018 Feb 6;4:45. doi: 10.1186/s40814-018-0237-0. eCollection 2018.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy